|
1 -> 79
|
MAGNDREPIGRKGKPTRPVKQKVSRRRYEDDDDYDDYDDYEDEEPMPRKGKGKGKGRKPRGKRGWLWLLLKLAIVFAVL
|
|
|
64 -> 87
|
GWLWLLLKLAIVFAVLIAIYGVYL
|
UniProt: Helical; Signal-anchor for type II membrane protein.
|
|
88 -> 250
|
DQKIRSRIDGKVWQLPAAVYGRMVNLEPDMTISKNEMVKLLEATQYRQVSKMTRPGEFTVQANSIEMIRRPFDFPDSKEGQVRARLTFDGDHLATIVNMENNRQFGFFRLDPRLITMISSPNGEQRLFVPRSGFPDLLVDTLLATEDRHFYEHDGISLYSIGR
|
UniProt: Membrane association; Sequence Annotation Type: region of interest.
|
|
103 -> 103
|
P
|
UniProt: In Ref. 1 and 2..
|
|
109 -> 109
|
R
|
R → G: decreased functionality - loss of fitness in a ΔmrcA background; purified protein has decreased basal glycosyltransferase and transpeptidase activity; decreased affinity for LpoB
|
|
112 -> 112
|
N
|
N → G: purified protein has increased basal transpeptidase and glycosyltransferase activity; increased affinity for LpoB
|
|
113 -> 197
|
LEPDMTISKNEMVKLLEATQYRQVSKMTRPGEFTVQANSIEMIRRPFDFPDSKEGQVRARLTFDGDHLATIVNMENNRQFGFFRL
|
|
|
134 -> 134
|
R
|
R → E: decreased functionality - loss of fitness in a ΔmrcA background; purified protein has increased basal glycosyltransferase and transpeptidase activity
|
|
157 -> 157
|
R
|
R → A: decreased functionality - loss of fitness in a ΔmrcA background; purified protein has decreased basal glycosyltransferase and transpeptidase activity; impacts (negatively) LpoB-mediated stimulation of glycosyltransferase activity
|
|
195 -> 367
|
FRLDPRLITMISSPNGEQRLFVPRSGFPDLLVDTLLATEDRHFYEHDGISLYSIGRAVLANLTAGRTVQGASTLTQQLVKNLFLSSERSYWRKANEAYMALIMDARYSKDRILELYMNEVYLGQSGDNEIRGFPLASLYYFGRPVEELSLDQQALLVGMVKGASIYNPWRNPK
|
UniProt: Transglycosylase; Sequence Annotation Type: region of interest.
|
|
196 -> 196
|
R
|
R → G: decreased functionality - loss of fitness in a ΔmrcA background
|
|
198 -> 198
|
D
|
D → A: decreased functionality - loss of fitness in a ΔmrcA background; purified protein has increased basal glycosyltransferase activity; impacts (negatively) LpoB-mediated stimulation of glycosyltransferase activity
|
|
202 -> 202
|
I
|
I → F: does not require the presence of LpoB for activity in vivo (at 30 °C only); elevated peptidoglycan glycosyltransferase activity in vitro.
|
|
209 -> 380
|
NGEQRLFVPRSGFPDLLVDTLLATEDRHFYEHDGISLYSIGRAVLANLTAGRTVQGASTLTQQLVKNLFLSSERSYWRKANEAYMALIMDARYSKDRILELYMNEVYLGQSGDNEIRGFPLASLYYFGRPVEELSLDQQALLVGMVKGASIYNPWRNPKLALERRNLVLRLL
|
|
|
233 -> 242
|
EDRHFYEHDG
|
Glycosyl transferase domain, conserved motif 1
|
|
234 -> 234
|
D
|
UniProt: 7-fold decrease in catalytic activity. No complementation in strain defective in PBP-1b..
|
|
264 -> 271
|
GASTLTQQ
|
Glycosyl transferase domain, conserved motif 2
|
|
286 -> 290
|
RKANE
|
Glycosyl transferase domain, conserved motif 3
|
|
290 -> 290
|
E
|
UniProt: 11-fold decrease in catalytic activity. Shows complementation activity in strain defective in PBP-1b..
|
|
303 -> 312
|
KDRILELYMN
|
Glycosyl transferase domain, conserved motif 4
|
|
313 -> 313
|
E
|
E → D: does not require the presence of LpoB for activity in vivo; elevated peptidoglycan glycosyltransferase activity in vitro.
|
|
318 -> 318
|
Q
|
Q → A: decreased functionality - loss of fitness in a ΔmrcA background; purified protein has decreased basal glycosyltransferase activity; impacts (positively) LpoB-mediated stimulation of glycosyltransferase activity and (negatively) LpoB-mediated stimulation of transpeptidase activity; produces glycan chains with a significantly decreased average length (~8 disaccharide units)
|
|
341 -> 341
|
E
|
E → A: decreased functionality - loss of fitness in a ΔmrcA background; purified protein has decreased basal glycosyltransferase and transpeptidase activity; impacts (negatively) LpoB-mediated stimulation of glycosyltransferase acitvity; increased affinity for LpoB
|
|
355 -> 355
|
K
|
K → A: decreased functionality - loss of fitness in a ΔmrcA background; purified protein has decreased basal glycosyltransferase activity and increased basal transpeptidase activity; impacts (positively) LpoB-mediated stimulation of glycosyltransferase activity
|
|
372 -> 377
|
RRNLVL
|
Glycosyl transferase domain, conserved motif 5
|
|
411 -> 411
|
Q
|
Q → R: does not require the presence of LpoB for activity in vivo; elevated peptidoglycan glycosyltransferase activity in vitro.
|
|
435 -> 447
|
GVKIFTTFDSVAQ
|
junction between the glycosyl transferase and acyl transferase modules of PBP1B
|
|
437 -> 437
|
K
|
K → A: decreased functionality - loss of fitness in a ΔmrcA background; purified protein has decreased basal glycosyltransferase activity; impacts (positively) LpoB-mediated stimulation of glycosyltransferase activity
|
|
443 -> 443
|
D
|
D → A: purified protein has increased basal glycosyltransferase and transpeptidase activity; enhances stimulatory effect of LpoB; increased affinity for LpoB
|
|
444 -> 736
|
SVAQDAAEKAAVEGIPALKKQRKLSDLETAIVVVDRFSGEVRAMVGGSEPQFAGYNRAMQARRSIGSLAKPATYLTALSQPKIYRLNTWIADAPIALRQPNGQVWSPQNDDRRYSESGRVMLVDALTRSMNVPTVNLGMALGLPAVTETWIKLGVPKDQLHPVPAMLLGALNLTPIEVAQAFQTIASGGNRAPLSALRSVIAEDGKVLYQSFPQAERAVPAQAAYLTLWTMQQVVQRGTGRQLGAKYPNLHLAGKTGTTNNNVDTWFAGIDGSTVTITWVGRDNNQPTKLYGA
|
UniProt: Transpeptidase; Sequence Annotation Type: region of interest.
|
|
473 -> 714
|
AIVVVDRFSGEVRAMVGGSEPQFAGYNRAMQARRSIGSLAKPATYLTALSQPKIYRLNTWIADAPIALRQPNGQVWSPQNDDRRYSESGRVMLVDALTRSMNVPTVNLGMALGLPAVTETWIKLGVPKDQLHPVPAMLLGALNLTPIEVAQAFQTIASGGNRAPLSALRSVIAEDGKVLYQSFPQAERAVPAQAAYLTLWTMQQVVQRGTGRQLGAKYPNLHLAGKTGTTNNNVDTWFAGID
|
|
|
510 -> 513
|
SLAK
|
Acyll transferase domain, conserved motif 7
|
|
572 -> 574
|
SMN
|
Acyl transferase domain, conserved motif 8
|
|
698 -> 700
|
KTG
|
Acyl transferase domain, conserved motif 9
|
|
754 -> 754
|
P
|
UniProt: In Ref. 2..
|
|
793 -> 828
|
LCQQSEMQQQPSGNPFDQSSQPQQQPQQQPAQQEQK
|
UniProt: Polar residues; Sequence Annotation Type: compositionally biased region.
|
|
68 -> 152
|
LLLKLAIVFAVLIAIYGVYLDQKIRSRIDGKVWQLPAAVYGRMVNLEPDMTISKNEMVKLLEATQYRQVSKMTRPGEFTVQANSI
|
|
|
164 -> 335
|
SKEGQVRARLTFDGDHLATIVNMENNRQFGFFRLDPRLITMISSPNGEQRLFVPRSGFPDLLVDTLLATEDRHFYEHDGISLYSIGRAVLANLTAGRTVQGASTLTQQLVKNLFLSSERSYWRKANEAYMALIMDARYSKDRILELYMNEVYLGQSGDNEIRGFPLASLYYF
|
|
|
428 -> 669
|
DKVKDLSGVKIFTTFDSVAQDAAEKAAVEGIPALKKQRKLSDLETAIVVVDRFSGEVRAMVGGSEPQFAGYNRAMQARRSIGSLAKPATYLTALSQPKIYRLNTWIADAPIALRQPNGQVWSPQNDDRRYSESGRVMLVDALTRSMNVPTVNLGMALGLPAVTETWIKLGVPKDQLHPVPAMLLGALNLTPIEVAQAFQTIASGGNRAPLSALRSVIAEDGKVLYQSFPQAERAVPAQAAYL
|
|